Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
Low
2.80
High
10.29
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BriaCell Therapeutics Corp | BCT | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.33% | 3.01 | 16:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.94 | 2.94 | 3.03 | 3.01 | 3.00 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 15 | 2,178 | - | 2.80 - 10.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:59:29 | 100 | $ 3.01 | CAD |
BriaCell Therapeutics Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 48.10M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BriaCell Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.00 | 3.19 | 2.80 | 3.01 | 3,351 | 0.01 | 0.33% |
| 1 Month | 3.64 | 4.08 | 2.80 | 3.57 | 7,995 | -0.63 | -17.31% |
| 3 Months | 5.34 | 5.79 | 2.80 | 3.87 | 9,560 | -2.33 | -43.63% |
| 6 Months | 6.77 | 8.00 | 2.80 | 4.72 | 6,945 | -3.76 | -55.54% |
| 1 Year | 9.61 | 10.29 | 2.80 | 6.22 | 5,568 | -6.60 | -68.68% |
| 3 Years | 10.84 | 15.05 | 2.80 | 8.19 | 7,378 | -7.83 | -72.23% |
| 5 Years | 10.84 | 15.05 | 2.80 | 8.19 | 7,378 | -7.83 | -72.23% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp. |
